[go: up one dir, main page]

WO2001072955A3 - Regulation of human nedd1-related protein - Google Patents

Regulation of human nedd1-related protein Download PDF

Info

Publication number
WO2001072955A3
WO2001072955A3 PCT/EP2001/003434 EP0103434W WO0172955A3 WO 2001072955 A3 WO2001072955 A3 WO 2001072955A3 EP 0103434 W EP0103434 W EP 0103434W WO 0172955 A3 WO0172955 A3 WO 0172955A3
Authority
WO
WIPO (PCT)
Prior art keywords
nedd1
human
related protein
regulation
neuronal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/003434
Other languages
French (fr)
Other versions
WO2001072955A2 (en
Inventor
Jiing-Ren Liou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2001262133A priority Critical patent/AU2001262133A1/en
Publication of WO2001072955A2 publication Critical patent/WO2001072955A2/en
Publication of WO2001072955A3 publication Critical patent/WO2001072955A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Human NEDD1-related protein can be regulated to treat or prevent diseases involving over-proliferation of cells of the central and peripheral nervous system, including, but not limited to, neuronal and glial tumors.
PCT/EP2001/003434 2000-03-27 2001-03-27 Regulation of human nedd1-related protein Ceased WO2001072955A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001262133A AU2001262133A1 (en) 2000-03-27 2001-03-27 Regulation of human nedd1-related protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19231900P 2000-03-27 2000-03-27
US60/192,319 2000-03-27

Publications (2)

Publication Number Publication Date
WO2001072955A2 WO2001072955A2 (en) 2001-10-04
WO2001072955A3 true WO2001072955A3 (en) 2002-04-18

Family

ID=22709160

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003434 Ceased WO2001072955A2 (en) 2000-03-27 2001-03-27 Regulation of human nedd1-related protein

Country Status (2)

Country Link
AU (1) AU2001262133A1 (en)
WO (1) WO2001072955A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107907515A (en) * 2017-11-23 2018-04-13 王颖皓 One kind detection glutathione probe reagent box and its detection method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EBI / SWALL [online] 1 February 1994 (1994-02-01), "NEDD1 protein (fragment)", XP002189267, accession no. P33215 *
KUMAR ET AL: "Identification of a set of genes with developmentally down-regulated expression in the mouse brain", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 185, no. 3, 30 June 1992 (1992-06-30), pages 1155 - 1161, XP000611569, ISSN: 0006-291X *

Also Published As

Publication number Publication date
AU2001262133A1 (en) 2001-10-08
WO2001072955A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
AU2002339128A1 (en) Use of reelin, gas6, and protein s in the treatment of neural disorders
AU9262598A (en) Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
WO2001012170A3 (en) Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
AU2001288628A1 (en) Method and reagents for treatment of skin disorders by modulating the notch pathway
AU7622198A (en) Methods of treating mental diseases, inflammation and pain
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
WO2001028494A3 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
MY138883A (en) Use of asiatic acid for treatment of cencer
WO2002015920A3 (en) Treatment of hyperproliferative diseases
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
AU6391000A (en) Method of preventing the injury or death of retinal cells and treating ocular diseases
WO2003049804A3 (en) Treatment of genitourinary tract disorders
AU6241096A (en) A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders
WO1999045103A3 (en) Human spinal cord cell lines and methods of use therefor
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
WO2001072955A3 (en) Regulation of human nedd1-related protein
AU5659798A (en) Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
WO2005056054A3 (en) METHODS OF INHIBITING APOPTOSIS USING INDUCERS OF NF-κB
AU3737500A (en) Method of preventing the death of retinal neurons and treating ocular diseases
WO2001034632A3 (en) Aliphatic hydroxy substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents
WO2004035082A3 (en) Proteins involved in the regulation of energy homeostasis
ZA9610264B (en) Preparation for use in the treatment of skin disorders.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP